Mild Cognitive Impairment in Patients with Hypertension

V.M. Kornatskyi, I.L. Revenko

Abstract


The paper discusses the efficiency of using choline alfoscerate (Gliatilin) in patients with hypertension and syndrome of mild cognitive impairment. The research was held within two months. The observation group included 28 people aged 50 to 70 years with the diagnosis of hypertension stage II, 2 degree, of high risk. The patients underwent neurological, neuropsychological, laboratory and instrumental investigations. The findings showed that the stabilization of blood pressure in combination with Gliatilin therapy had a positive effect on the general condition of patients, improved their cognitive functioning, stabilized emotional state.


Keywords


dementia; hypertension; mild cognitive impairment; choline alfoscerate

References


Деменция: приоритет общественного здравоохранения (2012); ВООЗ и международная организация по проблемам болезни Альцгеймера. — http://www.who.int/mental_health/publications/dementia_report_2012

Бачинська Н.Ю., Рожелюк І.Ф., Політаєва К.М., Холін В.О. Застосування мемантину гідрохлориду у хворих похилого віку на початкових стадіях судинної деменції і хвороби Альцгеймера // Лікарська справа. — 2013. — № 7. — С. 3-18.

Gearing M., Mirra S.S., Hedreen J. et al. The consortium to establish a registry for Alzheimer’s disease (CERAD). Part X. Neuropathology confirmation ofthe clinical diagnosis of Alzheimer’s disease // Neurology. — 1995. — Vol. 45, № 3. — P. 461- 466.

Nagy Z., Esiri M.M., Jobst K.A. et al. The effects of additional pathology on the cognitive deficit in Alzheimer disease // J. Neuropathol. Exp. Neurol. — 1997. — Vol. 56, № 2. — P. 165-170.

Гехт А.Б. Болезнь Альцгеймера и другие деменции // Журнал неврологии и психиатрии. — 2009. — Спецвып. — С. 17-20.

Anderson A.J., Pike C.J., Cotman C.W. Differential induction of immediate early gene proteins in cultured neurons by betaamyloid (A beta): association of cJun with A betainduced apoptosis // J. Neurochem. — 1995. — Vol. 65, № 4. — P. 1487-1498.

Banati R.B., Gehrmann J., Lannes-Vieira J. Inflammatory reaction in experimental autoimmune encephalomyelitis (EAE) is accompanied by a microglial expression of the beta A4-amyloid precursor protein (APP) // Glia. — 1995. — Vol. 14, № 3. — P. 209-215.

Moran M.A., Mufson E.J., Gomez-Ramos P. Cholinesterases colocalize with sites of neurofibrillary degeneration in aged and Alzheimers brains // Acta Neuropathol. Berl. — 1994. — Vol. 87, № 3. — P. 284-292.

Roman G.C. Vascular dementia: distinguishing characteristics, treatment, and prevention // J. Am. Geriatr. Soc. — 2003. — Vol. 51, № 5, suppl. 2. (Dementia). — P. S296-S304.

Iemolo F., Duro G., Rizzo C. Pathophysiology of vascular dementia // Immun. Ageing. — 2009. — Vol. 6. — 13.

Langa K.M., Foster N.L., Larson E.B. Mixed dementia: emerging concepts and therapeutic implications // JAMA. — 2004. — Vol. 292, № 23. — P. 2901-2908.

Schneider J.A., Wilson R.S., Bienias J.L. Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology // Neurology. — 2004. — Vol. 62, № 7. — P. 1148-1155.

Gorelick P.B. Risk factors for vascular dementia and Alzheimer disease // Stroke. — 2004. — Vol. 35, № 11. — P. 2620-2622.

Gorelick P.B., Scuteri A., Black S.E. et al.; American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association // Stroke. — 2011. — Vol. 42, № 9. — P. 2672-2713.

Мищенко Л.А. Антигипертензивная терапия и риск развития деменции // Терапия. — 2013. — № 9. — С. 61-62.

Elias M.F., Wolf P.A., D’Agostino et al. Untreated blood pressure level is inversely reated to cognitive functioning: the Fra­mingham Study // Am. J. Epidemiol. — 1993. — Vol. 138, № 6. — P. 353-364.

Tzourio C., Dufouil C., Ducimetiere P. Cognitive decline in individuals with high blood pressure: a longitudinal study in the elderly. EVA Study Group. Epidemiology of Vascular Aging // Neuro­logy. — 1999. — Vol. 53, № 9. — P. 1948-1952.

Ruitenberg A., Skoog I., Ott A. et al. Blood pressure and risk of dementia: results from the Rotterdam study and the Gothenburg H-70 Study // Dement. Geriatr. Cogn. Disord. — 2001. — Vol. 12, № 1. — P. 33-39.

Launer L.J., Masaki K., Petrovitch H. The association between midlife blood pressure level and late-life cognitive function. The Honolulu-Asia Aging Study // JAMA. — 1995. — Vol. 274, № 23. — P. 1846-1851.

Petersen R.S, Smith G.E., Warning S.C. Aging, memory and mild cognitive impairment // Int. Psychogeriatr. — 1997. — Vol. 9. — P. 24-32.

Захаров В.В. Диагностика и лечение умеренных когнитивных нарушений // Неврология, нейропсихиатрия, психосоматика. — 2009. — № 2. — С. 14-19.

Яхно Н.Н., Захаров В.В. Легкие когнитивные нарушения в пожилом возрасте // Неврологический журнал. — 2004. — № 1. — С. 4-8.

Petersen R.S., Smith G.E., Waring S.C. et al Mild cognitive impairment: clinical characterization and outcome // Arch. Neurol. — 1999. — Vol. 56. — P. 303-308.

Petersen R.C., Stevens J.C., Ganguli M. et al. Practice parameter. Early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology // Neurology. — 2001. — Vol. 56. — P. 1133-1142.

Ritchie K., Artero S., Touchon J. Classification criteria for mild cognitive impairment: a population-based validation study // Neurology. — 2001. — Vol. 56. — P. 37- 42.

Lucilla Parnetti, Francesco Amenta, Virgilio Galla. Choline alphoscerate in cognitive decline and in acute cerebrovascular disease: an analysis of published clinical data // Mechanisms of Ageing and Development. — 2001. — Vol. 122, Issue 16. — P. 2041-2055.

Кадыков А.С., Шахпаронова Н.В., Кашина Е.М. Возможности холинергической терапии больных с хроническими прогрессирующими сосудистыми заболеваниями головного мозга // Атмосфера. Нервные болезни. — 2006. — № 2. — С. 25-26 .

Di Perri R. et al. A multicentre trial to evaluate the efficacy and tolerability of alpha-glycerylphosphorylcholine versus cytosine diphosphocholine in patients with vascular dementia // J. Int. Med. Res. — 1991. — № 19 (4). — P. 330-341.

Moreno M. Cognitive improvement in mild to moderate Alzheimer dementia after treatment with the acetylcholine precursor choline alfoscerate: a multi-center, double-blind, randomized, placebo-controlled trial // Clin. Ther. — 2003. — Vol. 25, № 1. — P. 178-193.

Amenta F., Carotenuto A., Fasanaro A.M., Lanari A., Previdi P., Rea R. Analisi comparativa della sicurezza/efficacia degli inibitori delle colinesterasi e del precursore colinergico colina alfoscerato nelle demenze ad esordio nell’eta adulta // G. Gerontol. — 2010. — Vol. 58. — P. 64-68.




DOI: https://doi.org/10.22141/2224-0713.4.74.2015.78213

Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 INTERNATIONAL NEUROLOGICAL JOURNAL

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2017

 

 Яндекс.МетрикаSeo анализ сайта Рейтинг@Mail.ru